Zefroxe 250 mg Tablets
PDF Leaflet Revision Date: 27 January 2023
Clinical Summary
Quick overview from the medicine insert
Indication
Treatment of infections caused by susceptible organisms.
Dosage (summary)
Adults: 250-500 mg twice daily for 7-21 days; Children: 10-15 mg/kg twice daily.
Special Populations
- Renal impairment
- Hepatic impairment
Pregnancy & Breastfeeding
Safety not established; excreted in breast milk.
Key Drug Interactions
- Probenecid
- Furosemide
- Oral contraceptives
Contraindications
- Hypersensitivity to cephalosporins
- Pregnancy
- Breastfeeding
Common side effects
- Nausea
- Diarrhoea
- Headache
- Dizziness
Counselling Points
- Take with food for better absorption
- Shake suspension before use
- Monitor for allergic reactions
Serious warnings
- Serious hypersensitivity reactions
- Pseudomembranous colitis
Important Disclaimer
The Zefroxe 250 mg Tablets professional information leaflet below is the property of Ranbaxy Pharmaceuticals and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
